Actavis, Warner Chilcott, PLC Leap by Double Digits on Merger Talk

Published: May 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet. Shares of both companies soared in Friday trading. Actavis was formed in October through a $5.6 billion combination of Watson Pharmaceuticals of New Jersey and Actavis of Switzerland. It is one of the world's biggest generic drug companies. It sells versions of the deep vein thrombosis treatment Lovenox, asthma medication Xopenex, attention deficit hyperactivity disorder drugs Adderall XR and Concerta, heart drug Toprol XL, cholesterol fighter Lipitor, contraceptive Generess FE, and pain drug Kadian among many other products.

Help employers find you! Check out all the jobs and post your resume.

Back to news